1. Home
  2. AMRX vs CRGY Comparison

AMRX vs CRGY Comparison

Compare AMRX & CRGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • CRGY
  • Stock Information
  • Founded
  • AMRX 2002
  • CRGY 1986
  • Country
  • AMRX United States
  • CRGY United States
  • Employees
  • AMRX N/A
  • CRGY N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • CRGY Oil & Gas Production
  • Sector
  • AMRX Health Care
  • CRGY Energy
  • Exchange
  • AMRX Nasdaq
  • CRGY Nasdaq
  • Market Cap
  • AMRX 2.4B
  • CRGY 2.1B
  • IPO Year
  • AMRX N/A
  • CRGY N/A
  • Fundamental
  • Price
  • AMRX $8.38
  • CRGY $11.24
  • Analyst Decision
  • AMRX Strong Buy
  • CRGY Buy
  • Analyst Count
  • AMRX 5
  • CRGY 11
  • Target Price
  • AMRX $10.80
  • CRGY $17.56
  • AVG Volume (30 Days)
  • AMRX 1.8M
  • CRGY 4.5M
  • Earning Date
  • AMRX 05-02-2025
  • CRGY 05-05-2025
  • Dividend Yield
  • AMRX N/A
  • CRGY 4.28%
  • EPS Growth
  • AMRX N/A
  • CRGY N/A
  • EPS
  • AMRX N/A
  • CRGY N/A
  • Revenue
  • AMRX $2,793,957,000.00
  • CRGY $2,930,919,000.00
  • Revenue This Year
  • AMRX $10.49
  • CRGY $33.58
  • Revenue Next Year
  • AMRX $7.00
  • CRGY $0.92
  • P/E Ratio
  • AMRX N/A
  • CRGY N/A
  • Revenue Growth
  • AMRX 16.73
  • CRGY 23.01
  • 52 Week Low
  • AMRX $5.18
  • CRGY $9.88
  • 52 Week High
  • AMRX $9.48
  • CRGY $16.94
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 46.15
  • CRGY 38.47
  • Support Level
  • AMRX $8.18
  • CRGY $11.38
  • Resistance Level
  • AMRX $8.95
  • CRGY $11.77
  • Average True Range (ATR)
  • AMRX 0.31
  • CRGY 0.39
  • MACD
  • AMRX -0.08
  • CRGY 0.15
  • Stochastic Oscillator
  • AMRX 23.40
  • CRGY 60.87

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About CRGY Crescent Energy Company

Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.

Share on Social Networks: